SQI Diagnostics Expanding Its Proprietary Rapid Diagnostic Testing Portfolio Targeting Organ Transplant, Autoimmune Disease and Serological Testing

SQI Diagnostics Expanding Its Proprietary Rapid Diagnostic Testing Portfolio Targeting Organ Transplant, Autoimmune Disease and Serological Testing

SQI Diagnostics, Inc. CEO Mr. Robert L. Chioini stated, “Within our organ transplant, autoimmune disease, and serological testing business units we have multiple products in clinical development, and we believe these advanced tests have the potential to offer patients and consumers significant benefit once they receive regulatory approval.

Continue ReadingSQI Diagnostics Expanding Its Proprietary Rapid Diagnostic Testing Portfolio Targeting Organ Transplant, Autoimmune Disease and Serological Testing